Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu, Eric Q; Hodgkins, Paul; Ben-Hamadi, Rym; Setyawan, Juliana; Xie, Jipan; Sikirica, Vanja; Du, Ella X; Yan, Sherry Y; Erder, M Haim

Wu, Eric Q; Hodgkins, Paul; Ben-Hamadi, Rym; Setyawan, Juliana; Xie, Jipan; Sikirica, Vanja; Du, Ella X; Yan, Sherry Y; Erder, M Haim.

Affiliation

Wu EQ; Analysis Group, Inc., Boston, MA, USA. ewu@analysisgroup.com

CNS Drugs ; 26(7): 581-600, 2012 Jul 01.

Article in En | MEDLINE | ID: mdl-22712698

Subject(s)

Attention Deficit Disorder with Hyperactivity/drug therapy; Attention Deficit Disorder with Hyperactivity/economics; Central Nervous System Stimulants/economics; Central Nervous System Stimulants/therapeutic use; Australia; Central Nervous System Stimulants/adverse effects; Cost-Benefit Analysis; Europe; Humans; New Zealand; North America; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Central Nervous System Stimulants Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google